Skip to main content

Table 1 Clinical characteristics of study population stratified by gender (Mean ± SD)

From: Impact of nine common type 2 diabetes risk polymorphisms in Asian Indian Sikhs: PPARG2 (Pro12Ala), IGF2BP2, TCF7L2 and FTOvariants confer a significant risk

  

T2D Cases

NGT

 
 

Gender

532 (299M/233F)*

386 (184M/202F)

pvalue**

Age (yrs)

M*

53. 2 ± 11.1

51.7 ± 15.6

0.006

 

F

55.2 ± 11.0

50.8 ± 13.0

0.001

Age at

    

diagnosis (yrs)

M

47.5 ± 10.9

--

--

 

F

48.2 ± 10.5

--

--

Duration of

    

Diabetes (yrs)

M

8.6 ± 7.4

--

--

 

F

7.3 ± 6.0

--

--

BMI

M

26.6 ± 4.3

26.6 ± 4.4

0.912

 

F

29.0 ± 5.5

27.5 ± 4.9

<0.001

WHR†

M

0.99 ± 0.06

0.97 ± 0.07

0.002

 

F

0.93 ± 0.07

0.91 ± 0.07

<0.001

Fasting Glucose

    

(mmol/l)

M

10.1 ± 3.7

5.4 ± 0.6

<0.0001

 

F

10.0 ± 3.5

5.4 ± 0.5

<0.0001

Fasting

    

Insulin(IU/ml)

M

9.1 ± 7.9

11.0 ± 9.2

0.057

 

F

8.8 ± 7.4

11.5 ± 9.5

0.002

HbA1c (%)

M

8.6 ± 2.4

5.6 ± 0.7

<0.0001

 

F

8.6 ± 2.5

5.6 ± 0.7

<0.0001

  1. *M – male, F – female; †Waist to hip ratio; ** Difference between T2D cases and NGT controls